Pharmaceuticals | Bayer

You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it.

Partnering

orange

Innovation + Partnering

The future of cancer therapy is now

orange

Treatment + Care

Cancer is 100 diseases and each patient is unique

blue

Commitment + Responsibility

We support the EFPIA campaign
#WeWontRest

green

Innovation + Partnering

From molecules to medicine
Drug development: The R&D journey

orange

Cancer

blue

Healthy aging

green

Health policy

green

Innovation + Partnering

Open science in cancer research: everybody wins

orange

Argentina

Chagas Disease

“We believe Chagas is a children’s disease”, Dr Jaime Altcheh says, formulating an altogether radical theory about one of the greatest scourges to afflict Latin America.

Bayer sponsored clinical studies

Treatment + Care

Bayer trial finder

www.clinicaltrials.gov

Clinicaltrials.gov

www.clinicalstudydatarequest.com

Data sharing portal

Latest press release

Find us in your country

News

2018-07-09

XANTUS programme confirms low bleeding and low stroke rate with Xarelto® in 11,121 prospectively investigated patients with atrial fibrillation

2018-06-29

Bayer expands strategic alliance with Broad Institute of MIT and Harvard

2018-06-01

Bayer and MD Anderson Cancer Center to collaborate on development of novel cancer treatments

2018-05-29

U.S. FDA accepts larotrectinib New Drug Application and grants priority review

2018-05-17

Bayer highlights latest oncology research at ASCO 2018

Press center

#CoronaryArteryDisease (#CAD) often has no symptoms. However, if left untreated, can lead to heart attack or stroke…

Fish Soup | Easy Healthy Recipes #10

Partnering

The future of cancer therapy is now

Cancer is 100 diseases and each patient is unique

We support the EFPIA campaign
#WeWontRest

From molecules to medicine
Drug development: The R&D journey

Cancer

Healthy aging

Health policy

Open science in cancer research: everybody wins

Chagas Disease

“We believe Chagas is a children’s disease”, Dr Jaime Altcheh says, formulating an altogether radical theory about one of the greatest scourges to afflict Latin America.

How are you making #Time2Move at work? Leaving your desk every 90 minutes can help reduce risk of a blood clot.

Share below how you make #Time2Move!

Bayer trial finder

Clinicaltrials.gov

Data sharing portal

Latest press release

Find us in your country

News

XANTUS programme confirms low bleeding and low stroke rate with Xarelto® in 11,121 prospectively investigated patients with atrial fibrillation

Bayer expands strategic alliance with Broad Institute of MIT and Harvard

Bayer and MD Anderson Cancer Center to collaborate on development of novel cancer treatments

U.S. FDA accepts larotrectinib New Drug Application and grants priority review

Bayer highlights latest oncology research at ASCO 2018

Partnering

The future of cancer therapy is now

Cancer is 100 diseases and each patient is unique

We support the EFPIA campaign#WeWontRest

From molecules to medicine Drug development: The R&D journey

Cancer

Healthy aging

Health policy

Open science in cancer research: everybody wins

Chagas Disease

“We believe Chagas is a children’s disease”, Dr Jaime Altcheh says, formulating an altogether radical theory about one of the greatest scourges to afflict Latin America.

How are you making #Time2Move at work? Leaving your desk every 90 minutes can help reduce risk of a blood clot. Share below how you make #Time2Move!

#CoronaryArteryDisease (#CAD) often has no symptoms. However, if left untreated, can lead to heart attack or stroke…

Fish Soup | Easy Healthy Recipes #10

Bayer trial finder

Clinicaltrials.gov

Data sharing portal

Latest press release

Find us in your country

News

XANTUS programme confirms low bleeding and low stroke rate with Xarelto® in 11,121 prospectively investigated patients with atrial fibrillation

Bayer expands strategic alliance with Broad Institute of MIT and Harvard

Bayer and MD Anderson Cancer Center to collaborate on development of novel cancer treatments

U.S. FDA accepts larotrectinib New Drug Application and grants priority review

Bayer highlights latest oncology research at ASCO 2018

We support the EFPIA campaign
#WeWontRest

From molecules to medicine
Drug development: The R&D journey

How are you making #Time2Move at work? Leaving your desk every 90 minutes can help reduce risk of a blood clot.

Share below how you make #Time2Move!